Caroline Kurtz
5PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Sep 28, 2023
Efficacy and safety of a synthetic biotic for treatment of phenylketonuria: a phase 2 clinical trial.Jerry Vockley, Neal Sondheimer, Marja Puurunen
|Aug 16, 2022
Publisher Correction: Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study.Marja K Puurunen, Jerry Vockley, Shawn L Searle
|Jul 23, 2021
Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study.Marja K Puurunen, Jerry Vockley, Shawn L Searle
|Apr 10, 2020
Developing a new class of engineered live bacterial therapeutics to treat human diseases.Mark R Charbonneau, Vincent M Isabella, Ning Li
|Jan 18, 2019
An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans.Caroline B Kurtz, Yves A Millet, Marja K Puurunen
Pageof 1
Frequent Collaborators
4 joint publications
William S Denney
3 joint publications
Mark R Charbonneau
3 joint publications
Marja Puurunen
1 joint publications
Vincent M Isabella
1 joint publications
David A Wagner
1 joint publications
Kip A West
1 joint publications
Paul F Miller
1 joint publications
Jerry Vockley
1 joint publications
Neal Sondheimer
1 joint publications
Dorothy K Grange
